Related Experiment Video
Updated: Feb 26, 2026
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Anemarrhenae rhizoma water extract (AWE) ameliorates learning and memory impairments by activating the
Dongqin Wu1, Shuixin Chen1, Ruoying Liu1
1Jiangsu Safety Assessment and Research Center for Drug, Pesticide, and Veterinary Drug, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.
Background:
The scopolamine (SCOP)-induced memory impairment model is a classic model for cognitive research. The Notch signaling pathway is pivotal for synaptic plasticity.
Objective:
To investigate whether Anemarrhenae rhizoma water extract (AWE) ameliorates SCOP-induced synaptic dysfunction and memory impairment by activating the Notch pathway.
Methods:
UPLC-Q-TOF-MS was employed technology to analyze the components of AWE. behavioral tests and HE staining were performed to evaluate cognitive function and hippocampal pathology in mice, and DIA mass spectrometry was performed for a comprehensive analysis of the hippocampal proteome analysis. Additionally, Western blotting was performed to measure the expression levels of proteins related to the Notch signaling pathway and synapses. In vitro, HT22 cells were treated with the γ-secretase inhibitor DAPT and the selective ADAM17 inhibitor TAPI-1 to verify the crucial role of the Notch pathway in mediating the protective effects of AWE.
Results:
AWE primarily contains timosaponins BII, BIII, AI, AIII, neomangiferin, and mangiferin. Proteomic analysis revealed the upregulation of the key Notch pathway activators, ADAM17 and Aph-1, coupled with a significant overall enrichment of the Notch signaling pathway. Furthermore, AWE dose-dependently reversed SCOP-induced memory deficits, and pathological changes in the hippocampus and decreased expression of synaptic and Notch signaling proteins in mice. Critically, the protective effects of AWE on HT22 cells were completely abolished by DAPT and TAPI-1.
Conclusions:
AWE alleviates SCOP-induced synaptic protein loss and memory impairment by activating the Notch signaling pathway, providing new evidence for natural preventive strategies targeting Notch.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:23Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
01:13Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...